title: Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.
authors.affiliation: Blood and Marrow Transplant Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address: steven.devine@osumc.edu.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Devine
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D015328:Gene Rearrangement, B-Lymphocyte, Light Chain / Q000276:immunology; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D018579:Patient Selection; D057285:Precision Medicine; D012074:Remission Induction; D016019:Survival Analysis; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D008558:Melphalan
keywords: Light chain amyloidosis; Stem cell; Therapy; Transplantation